SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
US6875872B1
(en)
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
SE504459C2
(sv)
*
|
1994-07-15 |
1997-02-17 |
Astra Ab |
Förfarande för framställning av substituerade sulfoxider
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US6747155B2
(en)
|
1997-05-30 |
2004-06-08 |
Astrazeneca Ab |
Process
|
SE510650C2
(sv)
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
SE510643C2
(sv)
*
|
1997-06-27 |
1999-06-14 |
Astra Ab |
Termodynamiskt stabil omeprazol natrium form B
|
JP2002507996A
(ja)
|
1997-07-03 |
2002-03-12 |
デュポン ファーマシューティカルズ カンパニー |
神経学的障害を治療するためのイミダゾピリミジン類およびイミダゾピリジン類
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
SE9704183D0
(sv)
*
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New process
|
US6096340A
(en)
*
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
JP2002501897A
(ja)
*
|
1998-01-30 |
2002-01-22 |
セプラコール, インク. |
R−ランソプラゾール組成物及び方法
|
CA2330324A1
(en)
*
|
1998-04-30 |
1999-11-04 |
Sepracor Inc. |
S-rabeprazole compositions and methods
|
CA2330139A1
(en)
*
|
1998-04-30 |
1999-11-04 |
Sepracor Inc. |
R-rabeprazole compositions and methods
|
US6365589B1
(en)
|
1998-07-02 |
2002-04-02 |
Bristol-Myers Squibb Pharma Company |
Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
|
US6733778B1
(en)
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
CN1087739C
(zh)
*
|
1998-12-28 |
2002-07-17 |
中国科学院成都有机化学研究所 |
光学纯的苯并咪唑类抗消化性溃疡药物的包结拆分制备法
|
SE9900274D0
(sv)
*
|
1999-01-28 |
1999-01-28 |
Astra Ab |
New compound
|
TWI275587B
(en)
|
1999-06-17 |
2007-03-11 |
Takeda Chemical Industries Ltd |
A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
|
AU5705700A
(en)
|
1999-06-30 |
2001-01-22 |
Takeda Chemical Industries Ltd. |
Crystals of benzimidazole compounds
|
WO2001014366A1
(fr)
*
|
1999-08-25 |
2001-03-01 |
Takeda Chemical Industries, Ltd. |
Procede de preparation de derives optiquement actifs de sulfoxyde
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6316020B1
(en)
*
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
CN1193024C
(zh)
|
2000-04-28 |
2005-03-16 |
武田药品工业株式会社 |
生产旋光的亚砜衍生物的方法
|
KR100869677B1
(ko)
|
2000-05-15 |
2008-11-21 |
다케다 야쿠힌 고교 가부시키가이샤 |
결정의 제조방법
|
EP2281821B1
(de)
|
2000-05-15 |
2014-10-22 |
Takeda Pharmaceutical Company Limited |
Verfahren zur Herstellung eines Kristalls von (R)-2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazol
|
AU2001276721A1
(en)
|
2000-08-04 |
2002-02-18 |
Takeda Chemical Industries Ltd. |
Salts of benzimidazole compound and use thereof
|
ATE511508T1
(de)
*
|
2000-12-01 |
2011-06-15 |
Takeda Pharmaceutical |
Verfahren zur kristallisation von (r)- oder (s)- lansoprazol
|
JP2004536049A
(ja)
*
|
2001-04-13 |
2004-12-02 |
アプシンターム・リミテッド・ライアビリティ・カンパニー |
スルフィンアミドおよびスルホキシドの製造方法
|
GB2376231A
(en)
*
|
2001-06-06 |
2002-12-11 |
Cipla Ltd |
Benzimidazole-cyclodextrin inclusion complex
|
US20040006111A1
(en)
*
|
2002-01-25 |
2004-01-08 |
Kenneth Widder |
Transmucosal delivery of proton pump inhibitors
|
CA2474246C
(en)
|
2002-03-05 |
2010-06-29 |
Astrazeneca Ab |
Alkylammonium salts of omeprazole and esomeprazole
|
WO2003089408A2
(en)
*
|
2002-04-22 |
2003-10-30 |
Sun Pharmaceutical Industries Limited |
Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
|
US7169793B2
(en)
|
2002-06-27 |
2007-01-30 |
Dr. Reddy's Laboratories Limited |
Process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
|
AU2003273000A1
(en)
*
|
2002-10-16 |
2004-05-04 |
Takeda Pharmaceutical Company Limited |
Stable solid preparations
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
AU2003278406A1
(en)
|
2002-10-22 |
2004-05-13 |
Ranbaxy Laboratories Limited |
Amorphous form of esomeprazole salts
|
DE10254167A1
(de)
|
2002-11-20 |
2004-06-09 |
Icon Genetics Ag |
Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
|
JP2006514985A
(ja)
*
|
2002-12-06 |
2006-05-18 |
アルタナ ファルマ アクチエンゲゼルシャフト |
(s)−パントプラゾールの製造方法
|
EA011771B1
(ru)
*
|
2002-12-06 |
2009-06-30 |
Никомед Гмбх |
Способ получения оптически чистых ингибиторов протонного насоса
|
FR2848555B1
(fr)
|
2002-12-16 |
2006-07-28 |
Negma Gild |
Enantiomere(-)du tenatoprazole et son application en therapeutique
|
US20060122233A1
(en)
*
|
2002-12-16 |
2006-06-08 |
Yatendra Kumar |
Rabeprazole calcium
|
EP1572680A2
(de)
|
2002-12-19 |
2005-09-14 |
Eva Pharmaceutical Industries Ltd. |
Festkörper pantoprazol natrium,bekannte pantoprazol natrium hydraten, verfahren zu deren herstellungen.
|
WO2004060263A2
(en)
*
|
2003-01-07 |
2004-07-22 |
Ranbaxy Laboratories Limited |
Magnesium salt of imidazole derivative
|
EP1603537A4
(de)
*
|
2003-02-20 |
2009-11-04 |
Santarus Inc |
Neuartige formulierung, antazidkomplex-immediatfreisetzung für eine schnelle und anhaltende unterdrückung von magensäure
|
BRPI0407906A
(pt)
*
|
2003-02-28 |
2006-02-14 |
Ranbaxy Lab Ltd |
polimorfos de s-omeprazol
|
EP1601667A2
(de)
*
|
2003-03-12 |
2005-12-07 |
Teva Pharmaceutical Industries Limited |
Kristalline und amorphe festformen von pantoprazol und vervahren zu ihrer herstellung
|
WO2004080487A1
(ja)
*
|
2003-03-13 |
2004-09-23 |
Eisai Co. Ltd. |
歯ぎしりの予防剤または治療剤
|
FR2852956B1
(fr)
*
|
2003-03-28 |
2006-08-04 |
Negma Gild |
Procede de preparation enantioselective de derives de sulfoxydes
|
WO2004087702A2
(fr)
*
|
2003-03-28 |
2004-10-14 |
Sidem Pharma |
Procede de preparation enantioselective de derives de sulfoxydes.
|
WO2004099181A1
(en)
*
|
2003-05-05 |
2004-11-18 |
Ranbaxy Laboratories Limited |
Barium salt of benzimidazole derivative
|
EP1615913A2
(de)
|
2003-06-10 |
2006-01-18 |
Teva Pharmaceutical Industries Limited |
Verfahren zur herstellung von (pyridinyl)methyl]sulfinyl-substituierte benzimidazoles und neue chlorierte derivate von pantoprazole
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
SE0302381D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts I
|
SE0302382D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts II
|
AU2003288703A1
(en)
*
|
2003-12-05 |
2005-06-24 |
Hetero Drugs Limited |
A process for the preparation of substitited pyridinylmethylsulfinyl- benzimidazole enantiomers
|
SE0400410D0
(sv)
|
2004-02-20 |
2004-02-20 |
Astrazeneca Ab |
New compounds
|
US7176319B2
(en)
*
|
2004-04-28 |
2007-02-13 |
Hetero Drugs Limited |
Process for substituted sulfoxides
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
WO2005116011A1
(en)
*
|
2004-05-28 |
2005-12-08 |
Hetero Drugs Limited |
A novel stereoselective synthesis of benzimidazole sulfoxides
|
CN1960987A
(zh)
*
|
2004-06-02 |
2007-05-09 |
奥坦纳医药公司 |
制备吡啶-2-基甲基亚磺酰基-1h-苯并咪唑类化合物的方法
|
US8461187B2
(en)
|
2004-06-16 |
2013-06-11 |
Takeda Pharmaceuticals U.S.A., Inc. |
Multiple PPI dosage form
|
NZ551970A
(en)
*
|
2004-06-24 |
2010-01-29 |
Astrazeneca Ab |
New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
|
US20080249134A1
(en)
*
|
2004-06-24 |
2008-10-09 |
Ursula Hohlneicher |
New Esomeprazole Sodium Salt Crystal Modification
|
FR2876101B1
(fr)
*
|
2004-10-05 |
2007-03-02 |
Sidem Pharma Sa Sa |
Procede de preparation enantioselective de derives de sulfoxydes
|
DE602005016705D1
(de)
*
|
2004-10-11 |
2009-10-29 |
Ranbaxy Lab Ltd |
Verfahren zur herstellung substituierter sulfoxide
|
US7592111B2
(en)
*
|
2004-11-05 |
2009-09-22 |
Xerox Corporation |
Imaging member
|
CN101098867B
(zh)
*
|
2005-03-25 |
2010-08-11 |
丽珠医药集团股份有限公司 |
取代的亚砜类化合物和其制备方法及用途
|
CA2597632C
(en)
|
2005-03-25 |
2012-05-15 |
Livzon Pharmaceutical Group Inc. |
Substituted sulfoxide compounds, methods for preparing the same and use thereof
|
EP1885711A1
(de)
*
|
2005-05-06 |
2008-02-13 |
Glenmark Pharmaceuticals Limited |
Esomeprazol-strontiumsalz, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die dieses enthält
|
ES2432563T3
(es)
*
|
2005-06-08 |
2013-12-04 |
Lek Pharmaceuticals D.D. |
Solvato cristalino de omeprazol sódico
|
US20070043085A1
(en)
*
|
2005-08-19 |
2007-02-22 |
Glenmark Pharmaceuticals Limited |
Process for the preparation of amorphous form of neutral esomeprazole
|
KR20080076924A
(ko)
|
2005-12-05 |
2008-08-20 |
아스트라제네카 아베 |
에소메프라졸 비-염 형태의 제조를 위한 신규 방법
|
EP1801110A1
(de)
|
2005-12-22 |
2007-06-27 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Argininsalz des Esomeprazols
|
DE102005061720B3
(de)
*
|
2005-12-22 |
2006-10-19 |
Ratiopharm Gmbh |
Enantioselektive Herstellung von Benzimidazolderivaten und ihren Salzen
|
US7553857B2
(en)
|
2005-12-23 |
2009-06-30 |
Lek Pharmaceuticals D.D. |
S-omeprazole magnesium
|
ES2325336T3
(es)
|
2005-12-28 |
2009-09-01 |
Union Quimico-Farmaceutica, S.A. |
Procedimiento para la preparacion del enantiomero (s) de omeprazol.
|
CN1810803B
(zh)
*
|
2006-02-17 |
2010-11-17 |
中国科学院上海有机化学研究所 |
高对映体选择性制备(s)-奥美拉唑的方法
|
US7579476B2
(en)
*
|
2006-02-24 |
2009-08-25 |
Praktikatalyst Pharma, Llc |
Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
|
US8063074B2
(en)
*
|
2006-05-04 |
2011-11-22 |
Dr. Reddy's Laboratories Limited |
Polymorphic forms of esomeprazole sodium
|
US7786309B2
(en)
*
|
2006-06-09 |
2010-08-31 |
Apotex Pharmachem Inc. |
Process for the preparation of esomeprazole and salts thereof
|
MX2008016196A
(es)
|
2006-07-05 |
2009-01-20 |
Lupin Ltd |
Proceso para la preparacion de enantiomeros opticamente puros u opticamente enriquecidos de compuestos de sulfoxido.
|
US8173818B2
(en)
|
2006-08-08 |
2012-05-08 |
Jubilant Organosys Limited |
Process for producing sulphoxide compounds
|
WO2008047681A1
(fr)
|
2006-10-13 |
2008-04-24 |
Eisai R & D Management Co., Ltd. |
Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique
|
JP2009196894A
(ja)
*
|
2006-10-13 |
2009-09-03 |
Eisai R & D Management Co Ltd |
スルフィニルベンズイミダゾール化合物またはその塩の製造方法
|
EP1947099A1
(de)
|
2007-01-18 |
2008-07-23 |
LEK Pharmaceuticals D.D. |
Verfahren zur Entfernung von Lösungsmitteln in Omeprazol-Salzen
|
JP2010519284A
(ja)
|
2007-02-21 |
2010-06-03 |
シプラ・リミテッド |
エソメプラゾールマグネシウム二水和物の調製方法
|
EP2152691B1
(de)
*
|
2007-06-07 |
2011-11-23 |
Aurobindo Pharma Limited |
Verbessertes verfahren zur herstellung eines optisch aktiven protonenpumpenhemmers
|
CN101323609B
(zh)
*
|
2007-06-15 |
2013-05-01 |
成都福瑞生物工程有限公司 |
不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
|
WO2009066321A2
(en)
*
|
2007-10-03 |
2009-05-28 |
Ipca Laboratories Limited |
Process for optically active sulfoxide compounds
|
WO2009047775A2
(en)
|
2007-10-08 |
2009-04-16 |
Hetero Drugs Limited |
Polymorphs of esomeprazole salts
|
AU2008310735B2
(en)
|
2007-10-12 |
2013-09-12 |
Takeda Pharmaceutical Company Limited |
Methods of treating gastrointestinal disorders independent of the intake of food
|
FR2925899B1
(fr)
*
|
2007-12-27 |
2012-12-21 |
Sidem Pharma Sa |
Procede de preparation enantioselective de sulfoxydes.
|
CN101492459B
(zh)
*
|
2008-01-25 |
2011-04-27 |
山东轩竹医药科技有限公司 |
含烷氧乙酰基二氢异噁唑并吡啶化合物
|
CN101497603B
(zh)
*
|
2008-01-30 |
2012-11-07 |
山东轩竹医药科技有限公司 |
含有被烷氧烷胺氧基取代的吡啶的苯并咪唑衍生物
|
KR20100123758A
(ko)
|
2008-03-10 |
2010-11-24 |
다케다 야쿠힌 고교 가부시키가이샤 |
벤즈이미다졸 화합물의 결정
|
EP2265605A4
(de)
*
|
2008-03-18 |
2011-08-03 |
Reddys Lab Ltd Dr |
Herstellungsverfahren für dexlansoprazol und polymorphe davon
|
CN101538264A
(zh)
*
|
2008-03-19 |
2009-09-23 |
中国科学院成都有机化学有限公司 |
手性亚砜类化合物的制备新方法
|
WO2009145368A1
(en)
*
|
2008-05-27 |
2009-12-03 |
Sk Chemicals Co., Ltd. |
Improved preparing method of (s)-omeprazole from omeprazole racemate using optical resolution agent
|
EP2143722A1
(de)
|
2008-07-09 |
2010-01-13 |
Lek Pharmaceuticals D.D. |
Verfahren zur Herstellung von Esomeprazol-Natrium von hoher chemischer Reinheit und neue Formen von Esomeprazol-Natrium
|
WO2010039885A2
(en)
*
|
2008-09-30 |
2010-04-08 |
Teva Pharmaceutical Industries Ltd. |
Crystalline forms of dexlansoprazole
|
EP2264024A1
(de)
|
2008-10-14 |
2010-12-22 |
LEK Pharmaceuticals d.d. |
Verfahren zur Herstellung einer enantiomerisch-angereicherte Protonpumpenhemmer
|
IT1391776B1
(it)
|
2008-11-18 |
2012-01-27 |
Dipharma Francis Srl |
Procedimento per la preparazione di dexlansoprazolo
|
CZ200990A3
(cs)
*
|
2009-02-16 |
2010-08-25 |
Zentiva, K.S. |
Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu
|
WO2010097583A1
(en)
|
2009-02-24 |
2010-09-02 |
Cipla Limited |
Esomeprazole potassium polymorph and its preparation
|
CZ2009172A3
(cs)
*
|
2009-03-17 |
2010-09-29 |
Zentiva, K.S. |
Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu
|
US20130030186A1
(en)
*
|
2009-06-02 |
2013-01-31 |
Sun Pharmaceutical Industries Limited |
Process for preparing sulphoxide compounds
|
IT1395118B1
(it)
|
2009-07-29 |
2012-09-05 |
Dipharma Francis Srl |
Procedimento per la preparazione di dexlansoprazolo cristallino
|
US8748619B2
(en)
|
2009-11-12 |
2014-06-10 |
Hetero Research Foundation |
Process for the resolution of omeprazole
|
US20130197232A1
(en)
|
2010-01-29 |
2013-08-01 |
Ranbaxy Laboratories Limited |
Process for the preparation of crystalline forms of dexlansoprazole
|
KR20130087509A
(ko)
|
2010-06-24 |
2013-08-06 |
씨아이피엘에이 엘티디. |
덱스라베프라졸의 염 및 다형체
|
CN101914090B
(zh)
*
|
2010-08-13 |
2013-03-20 |
埃斯特维华义制药有限公司 |
左旋奥美拉唑的制备方法
|
CN102558150B
(zh)
*
|
2010-12-31 |
2014-03-12 |
正大天晴药业集团股份有限公司 |
取代亚砜化合物的合成方法
|
CN102321071B
(zh)
*
|
2011-07-20 |
2013-01-23 |
江苏奥赛康药业股份有限公司 |
一种高纯度埃索美拉唑钠的工业化生产方法
|
CN102977076A
(zh)
*
|
2011-09-02 |
2013-03-20 |
扬子江药业集团上海海尼药业有限公司 |
一种右兰索拉唑的制备方法
|
CN102329302A
(zh)
*
|
2011-10-22 |
2012-01-25 |
刘强 |
一种埃索美拉唑及其盐的制备方法
|
CN102408412A
(zh)
*
|
2011-10-25 |
2012-04-11 |
广东华南药业集团有限公司 |
高对映体选择性制备(s)- 奥美拉唑的方法
|
CN102432412A
(zh)
*
|
2011-10-28 |
2012-05-02 |
成都欣捷高新技术开发有限公司 |
一种手性亚砜类质子泵抑制剂或其可药用盐的制备方法
|
KR101300950B1
(ko)
*
|
2011-10-31 |
2013-08-27 |
르노삼성자동차 주식회사 |
전기자동차의 공기 흡입 장치
|
WO2013140120A1
(en)
|
2012-03-22 |
2013-09-26 |
Cipla Limited |
Glycerol solvate forms of (r) - 2 - [ [ [3 -methyl -4 (2,2, 2 - trifluoroethoxy) pyridin- 2 - yl] methyl] sulphinyl] - 1h - ben zimidazole
|
CN102633776B
(zh)
*
|
2012-03-28 |
2014-06-18 |
中山市仁合药业有限公司 |
一种埃索美拉唑及其钠盐的制备方法
|
CN102659763B
(zh)
*
|
2012-04-27 |
2014-01-22 |
南京优科生物医药研究有限公司 |
一种右旋兰索拉唑合成与纯化的方法
|
CN103044402B
(zh)
*
|
2012-12-31 |
2015-01-14 |
康普药业股份有限公司 |
埃索美拉唑钠合成生产方法
|
CN103113351B
(zh)
*
|
2013-03-08 |
2015-01-21 |
苏州特瑞药业有限公司 |
一种光学纯手性亚砜类化合物的制备方法
|
CN104177336A
(zh)
*
|
2013-05-28 |
2014-12-03 |
上海汇伦生命科技有限公司 |
一种对映选择性合成右兰索拉唑的方法
|
EP2933002A1
(de)
|
2014-04-11 |
2015-10-21 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Pharmazeutische kombinationen von dabigatran und protonenpumpeninhibitoren
|
WO2015155307A1
(en)
|
2014-04-11 |
2015-10-15 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical combinations of rivaroxaban and proton pump inhibitors
|
EP2980086B1
(de)
|
2014-07-29 |
2016-06-15 |
F.I.S.- Fabbrica Italiana Sintetici S.p.A. |
Effizientes Verfahren zur Herstellung von Esomeprazol (S)-Binol Komplex
|
WO2016104668A1
(ja)
*
|
2014-12-26 |
2016-06-30 |
国立大学法人 東京大学 |
光学活性のプロトンポンプ阻害化合物の製造方法
|
CN104610226A
(zh)
*
|
2014-12-31 |
2015-05-13 |
广东东阳光药业有限公司 |
一种右兰索拉唑的不对称氧化方法
|
ES2615637T3
(es)
|
2015-03-06 |
2017-06-07 |
F.I.S.- Fabbrica Italiana Sintetici S.P.A. |
Procedimiento mejorado para la purificación óptica del esomeprazol
|
CN105218391B
(zh)
*
|
2015-07-09 |
2017-11-21 |
天津青松华药医药有限公司 |
L‑酒石酸单酯单酰胺类化合物
|
CN105218392B
(zh)
*
|
2015-07-09 |
2017-11-21 |
天津青松华药医药有限公司 |
D‑酒石酸单酯单酰胺类化合物
|
CN105968097B
(zh)
*
|
2016-05-17 |
2019-05-03 |
杭州华东医药集团新药研究院有限公司 |
左旋泮托拉唑的工业化生产方法
|
CN106083818A
(zh)
*
|
2016-06-08 |
2016-11-09 |
扬子江药业集团有限公司 |
一种高纯度埃索美拉唑钠的制备方法
|
CN106366070B
(zh)
*
|
2016-08-10 |
2019-06-11 |
上海万巷制药有限公司 |
一种高纯度埃索美拉唑钠的制备方法
|
CN106632249A
(zh)
*
|
2016-09-30 |
2017-05-10 |
青岛云天生物技术有限公司 |
一种制备(s)‑泮托拉唑钠的方法
|
CN106632248A
(zh)
*
|
2016-09-30 |
2017-05-10 |
青岛云天生物技术有限公司 |
一种左旋泮托拉唑钠的制备工艺
|
CN106866630B
(zh)
*
|
2017-04-01 |
2018-08-07 |
上海华源医药科技发展有限公司 |
一种右兰索拉唑的制备方法
|
CN110698482A
(zh)
*
|
2019-10-29 |
2020-01-17 |
株洲千金药业股份有限公司 |
一种s型手性亚砜类化合物的制备方法
|
CN110746428A
(zh)
*
|
2019-10-29 |
2020-02-04 |
株洲千金药业股份有限公司 |
一种r型手性亚砜类化合物的制备方法
|
CN113845510A
(zh)
*
|
2020-06-27 |
2021-12-28 |
鲁南制药集团股份有限公司 |
一种埃索美拉唑的制备方法
|